American Century Companies’s Acorda Therapeutics ACOR Stock Holding History

American Century Companies’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,596	Closed	-$2.55M	–	1369
2019 Q1	$2.55M	Buy	1,596 +234	+17%	+$422K	﹤0.01%	958
2018 Q4	$2.55M	Buy	1,362 +166	+14%	+$361K	﹤0.01%	931
2018 Q3	$2.82M	Buy	+1,196	New	+$3.7M	﹤0.01%	968
2016 Q2	–	Sell	-738	Closed	-$2.34M	–	1415
2016 Q1	$2.34M	Sell	738 -669	-48%	-$2.78M	﹤0.01%	971
2015 Q4	$7.22M	Sell	1,407 -375	-21%	-$1.64M	0.01%	716
2015 Q3	$5.67M	Buy	1,782 +399	+29%	+$1.55M	0.01%	792
2015 Q2	$5.53M	Buy	1,383 +98	+8%	+$379K	0.01%	807
2015 Q1	$5.13M	Sell	1,285 -57	-4%	-$261K	0.01%	828
2014 Q4	$6.58M	Buy	1,342 +1,061	+378%	+$4.55M	0.01%	797
2014 Q3	$1.14M	Buy	281 +12	+4%	+$45K	﹤0.01%	1153
2014 Q2	$1.09M	Sell	269 -9	-3%	-$36.7K	﹤0.01%	1201
2014 Q1	$1.26M	Sell	278 -7	-2%	-$28.3K	﹤0.01%	1183
2013 Q4	$1M	Sell	285 -65	-19%	-$253K	﹤0.01%	1243
2013 Q3	$1.44M	Buy	350 +17	+5%	+$73.2K	﹤0.01%	1164
2013 Q2	$1.32M	Buy	+333	New	+$1.37M	﹤0.01%	1164

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

American Century Companies's ACOR Position: Q2 2019 in Review

American Century Companies sold out of Acorda Therapeutics (ACOR) in Q2 2019, closing a stake of 1,596 shares — an estimated $2.55M sold.

American Century Companies first reported a position in ACOR in Q2 2013 and held it in 15 quarters. The position peaked at $7.22M in Q4 2015. 163 funds tracked by Wall St. Rank hold ACOR as of Q2 2019.

American Century Companies reported no remaining Acorda Therapeutics position as of Q2 2019 after selling out during the quarter.
American Century Companies sold 1,596 Acorda Therapeutics shares in Q2 2019, an estimated $2.55M.
American Century Companies first reported a position in Acorda Therapeutics in Q2 2013 and held it in 15 quarters.
American Century Companies's Acorda Therapeutics position peaked at $7.22M in Q4 2015.
163 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2019.

Based on American Century Companies's 13F filing for Q2 2019, filed 14 Aug 2019.